Wellness Resources News
Science-based natural health news to help you take charge of your health!
Our mission & writing commitment-
February 22, 2024
Nicotinamide is a potent inhibitor of proinflammatory cytokines.The present study investigates the modulating effects of nicotinamide on the cytokine response to endotoxin. In an in vitro model of endotoxaemia, human [...]
-
February 22, 2024
Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent DeacetylatiThis study investigated the effect of nicotinamide (NAM) supplementation on the development of brain inflammation and microglial activation in a mouse [...]
-
February 22, 2024
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochonNicotinamide adenine dinucleotide (NAD) is a REDOX cofactor and metabolite essential for neuronal survival. Glaucoma is a common neurodegenerative disease [...]
-
February 22, 2024
Niacin - a scoping review for Nordic Nutrition Recommendations 2023.Niacin is the precursor to pyridine nucleotides NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide adenine dinucleotide phosphate). Niacin [...]
-
February 22, 2024
Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patienBackground: Nicotinamide has been reported to protect against liver steatosis and metabolic imbalances in nonalcoholic fatty liver disease (NAFLD) in [...]
-
February 22, 2024
Nicotinamide and ascorbic acid nanoparticles against the hepatic insult inducedAims: Non-alcoholic fatty liver disease (NAFLD) caused by consumption of high levels of fat and sugars (HFHS) in diet is considered one of the most [...]
-
February 22, 2024
Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C oBackground: The liver disease is one of the most important traditional public health problems in Egypt. Oxidative stress is attributed to such [...]
-
February 22, 2024
Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-rNinety percent depancreatized rats received daily intraperitoneal injection of 0.5 g/kg nicotinamide and 0.05 g/kg 3-aminobenzamide, potent inhibitors of [...]
-
February 22, 2024
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).Nicotinamide has been recently introduced, in addition to intensive insulin therapy for patients with recent-onset insulin-dependent diabetes mellitus [...]